Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.72%
- Poor long term growth as Net Sales has grown by an annual rate of 4.45% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.00
2
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-29.3%
0%
-29.3%
6 Months
-32.46%
0%
-32.46%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Rhön-Klinikum AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.53%
EBIT Growth (5y)
17.72%
EBIT to Interest (avg)
1.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
1.04
Tax Ratio
20.54%
Dividend Payout Ratio
15.44%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
1.54%
ROE (avg)
1.72%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.60
EV to EBIT
12.29
EV to EBITDA
5.33
EV to Capital Employed
0.53
EV to Sales
0.35
PEG Ratio
2.55
Dividend Yield
0.34%
ROCE (Latest)
4.30%
ROE (Latest)
3.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2018
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
418.80
392.70
6.65%
Operating Profit (PBDIT) excl Other Income
24.00
23.90
0.42%
Interest
0.80
0.80
Exceptional Items
0.10
-0.00
Consolidate Net Profit
7.40
9.40
-21.28%
Operating Profit Margin (Excl OI)
21.90%
21.90%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 6.65% vs 13.89% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -21.28% vs 62.07% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,826.90
1,672.50
9.23%
Operating Profit (PBDIT) excl Other Income
74.10
45.70
62.14%
Interest
3.10
3.70
-16.22%
Exceptional Items
-3.70
1.90
-294.74%
Consolidate Net Profit
45.20
40.20
12.44%
Operating Profit Margin (Excl OI)
6.30%
-11.60%
1.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 9.23% vs 2.49% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 12.44% vs 49.44% in Dec 2023
About Rhön-Klinikum AG 
Rhön-Klinikum AG
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






